Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Brandinfo Shinhan Life wishes to contribute to the sustainable development of Việt Nam's future generations
Media-OutReach Newswire LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China
Media-OutReach Newswire The Malaysia Healthcare Travel Council: Upholding Medical Innovations as a Cancer Care Centre of Excellence
Media-OutReach Newswire Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth